Luoxin Pharmaceuticals Group Stock Co Ltd
Luoxin Pharmaceuticals Group Stock Co., Ltd. engages in the research and development, manufacture, and trading of drugs in China. The company provides antiviral, anti-infective, respiratory and digestive system, nervous and endocrine system, cardiovascular system, oncology, and anti-allergic APIs and intermediates, as well as antipyretic, analgesics, and anti-inflammatory APIs and intermediates. … Read more
Luoxin Pharmaceuticals Group Stock Co Ltd (002793) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.059x
Based on the latest financial reports, Luoxin Pharmaceuticals Group Stock Co Ltd (002793) has a cash flow conversion efficiency ratio of 0.059x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥90.75 Million) by net assets (CN¥1.53 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Luoxin Pharmaceuticals Group Stock Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2024)
This chart illustrates how Luoxin Pharmaceuticals Group Stock Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Luoxin Pharmaceuticals Group Stock Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Luoxin Pharmaceuticals Group Stock Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Bandwidth Inc
NASDAQ:BAND
|
0.057x |
|
Zhangjiagang Freetrade Science and Technology Co Ltd
SHG:600794
|
-0.023x |
|
Alto Neuroscience, Inc.
NYSE:ANRO
|
-0.089x |
|
EQ Resources Ltd
AU:EQR
|
-0.351x |
|
Hangzhou Huning Elevator Parts Co Ltd
SHE:300669
|
0.008x |
|
Soho House & Co Inc.
NYSE:SHCO
|
-0.100x |
|
Fubotv Inc
NYSE:FUBO
|
-0.076x |
|
HEALTHCARE TR.PFD SH DL25
F:4ON
|
N/A |
Annual Cash Flow Conversion Efficiency for Luoxin Pharmaceuticals Group Stock Co Ltd (2011–2024)
The table below shows the annual cash flow conversion efficiency of Luoxin Pharmaceuticals Group Stock Co Ltd from 2011 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥1.46 Billion | CN¥-157.85 Million | -0.108x | -150.33% |
| 2023-12-31 | CN¥2.57 Billion | CN¥552.79 Million | 0.215x | +175.66% |
| 2022-12-31 | CN¥3.31 Billion | CN¥-939.13 Million | -0.284x | -1215.03% |
| 2021-12-31 | CN¥4.74 Billion | CN¥120.63 Million | 0.025x | +442.04% |
| 2020-12-31 | CN¥4.35 Billion | CN¥-32.40 Million | -0.007x | -125.36% |
| 2019-12-31 | CN¥3.96 Billion | CN¥116.33 Million | 0.029x | -76.59% |
| 2018-12-31 | CN¥909.89 Million | CN¥114.12 Million | 0.125x | -7.52% |
| 2017-12-31 | CN¥754.19 Million | CN¥102.27 Million | 0.136x | +30.19% |
| 2016-12-31 | CN¥698.33 Million | CN¥72.74 Million | 0.104x | -39.16% |
| 2015-12-31 | CN¥339.50 Million | CN¥58.12 Million | 0.171x | +29.11% |
| 2014-12-31 | CN¥315.46 Million | CN¥41.83 Million | 0.133x | -48.50% |
| 2013-12-31 | CN¥251.50 Million | CN¥64.75 Million | 0.257x | +58.84% |
| 2012-12-31 | CN¥205.54 Million | CN¥33.31 Million | 0.162x | -47.10% |
| 2011-12-31 | CN¥151.87 Million | CN¥46.53 Million | 0.306x | -- |